HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.

Abstract
Androgen-insensitive DU145 and PC3 human prostate cancer cells express high levels of specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4, and treatment of cells with methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate (CDODA-Me) inhibited cell growth and downregulated Sp1, Sp3, and Sp4 expression. CDODA-Me (15 mg/kg/d) was a potent inhibitor of tumor growth in a mouse xenograft model (PC3 cells) and also decreased expression of Sp transcription factors in tumors. CDODA-Me-mediated downregulation of Sp1, Sp3, and Sp4 was due to induction of the transcriptional repressor ZBTB4, which competitively binds and displaces Sp transcription factors from GC-rich sites in Sp1-, Sp3-, Sp4-, and Sp-regulated gene promoters. ZBTB4 levels are relatively low in DU145 and PC3 cells due to suppression by miR paralogs that are members of the miR-17-92 (miR-20a/17-5p) and miR-106b-25 (miR-106b/93) clusters. Examination of publically available prostate cancer patient array data showed an inverse relationship between ZBTB4 and miRs-20a/17-5p/106b/93 expression, and increased ZBTB4 in patients with prostate cancer was a prognostic factor for increased survival. CDODA-Me induces ZBTB4 in prostate cancer cells through disruption of miR-ZBTB4 interactions, and this results in downregulation of pro-oncogenic Sp transcription factors and Sp-regulated genes.
AuthorsKyounghyun Kim, Gayathri Chadalapaka, Satya S Pathi, Un-Ho Jin, Ju-Seog Lee, Yun-Yong Park, Sung-Gook Cho, Sudhakar Chintharlapalli, Stephen Safe
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 11 Issue 9 Pg. 1852-62 (Sep 2012) ISSN: 1538-8514 [Electronic] United States
PMID22752225 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2012 AACR.
Chemical References
  • Antineoplastic Agents
  • MIRN106 microRNA, human
  • MIRN17 microRNA, human
  • MIRN25 microRNA, human
  • MIRN92 microRNA, human
  • MicroRNAs
  • Repressor Proteins
  • Sp Transcription Factors
  • ZBTB4 protein, human
  • methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate
  • Luciferases
  • Glycyrrhetinic Acid
Topics
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Genes, Reporter
  • Glycyrrhetinic Acid (analogs & derivatives, pharmacology, therapeutic use)
  • Humans
  • Luciferases (biosynthesis, genetics)
  • Male
  • Mice
  • Mice, Nude
  • MicroRNAs (genetics)
  • Multigene Family
  • Promoter Regions, Genetic
  • Prostatic Neoplasms (drug therapy, metabolism, pathology)
  • Repressor Proteins (genetics, metabolism)
  • Sp Transcription Factors (genetics, metabolism)
  • Transcriptional Activation
  • Tumor Burden (drug effects)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: